Shane Thomas Gleason - 27 Jan 2025 Form 4 Insider Report for InspireMD, Inc. (NSPR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 May 2026, 17:16:56 UTC
Prior SEC filing
10 Jan 2025
Next SEC filing
16 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Lawless, Attorney-in-Fact for Shane Gleason

Key filing fact

Shane Thomas Gleason filed Form 4 for InspireMD, Inc. (NSPR) on 21 May 2026.

Key facts

  • This page summarizes Shane Thomas Gleason's Form 4 filing for InspireMD, Inc. (NSPR).
  • 14 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 21 May 2026, 17:16.

Change

  • Previous filing in this sequence was filed on 10 Jan 2025.
  • Current net transaction value: -$189,594.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001966214 Primary reporting owner

Gleason Shane Thomas

Relationship
Chief Commercial Officer
Address
C/O INSPIREMD, INC., 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI
Signature
/s/ Michael Lawless, Attorney-in-Fact for Shane Gleason
Signature date
21 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NSPR transaction

Common Stock

Sale

Transaction value
$10,455
Shares
-3,858
Change %
-0.34%
Price
$2.71
Shares after
1,135,319
Date
27 Jan 2025
Ownership
Direct
Footnotes
F1
NSPR transaction

Common Stock

Sale

Transaction value
$6,462
Shares
-2,476
Change %
-0.22%
Price
$2.61
Shares after
1,132,843
Date
28 Jan 2025
Ownership
Direct
Footnotes
F1
NSPR transaction

Common Stock

Sale

Transaction value
$9,004
Shares
-3,660
Change %
-0.32%
Price
$2.46
Shares after
1,129,183
Date
29 Jan 2025
Ownership
Direct
Footnotes
F1
NSPR transaction

Common Stock

Sale

Transaction value
$6,160
Shares
-2,454
Change %
-0.22%
Price
$2.51
Shares after
1,126,729
Date
30 Jan 2025
Ownership
Direct
Footnotes
F1
NSPR transaction

Common Stock

Sale

Transaction value
$25,304
Shares
-9,923
Change %
-0.88%
Price
$2.55
Shares after
1,116,806
Date
31 Jan 2025
Ownership
Direct
Footnotes
F1
NSPR transaction

Common Stock

Sale

Transaction value
$17,753
Shares
-7,073
Change %
-0.63%
Price
$2.51
Shares after
1,109,733
Date
03 Feb 2025
Ownership
Direct
Footnotes
F1
NSPR transaction

Common Stock

Sale

Transaction value
$12,625
Shares
-5,132
Change %
-0.46%
Price
$2.46
Shares after
1,104,601
Date
04 Feb 2025
Ownership
Direct
Footnotes
F1
NSPR transaction

Common Stock

Sale

Transaction value
$36,500
Shares
-10,000
Change %
-0.91%
Price
$3.65
Shares after
1,094,601
Date
25 Feb 2025
Ownership
Direct
Footnotes
F1
NSPR transaction

Common Stock

Sale

Transaction value
$6,230
Shares
-2,482
Change %
-0.23%
Price
$2.51
Shares after
1,092,119
Date
23 May 2025
Ownership
Direct
Footnotes
F1
NSPR transaction

Common Stock

Sale

Transaction value
$3,946
Shares
-1,572
Change %
-0.14%
Price
$2.51
Shares after
1,090,547
Date
27 May 2025
Ownership
Direct
Footnotes
F1
NSPR transaction

Common Stock

Sale

Transaction value
$9,438
Shares
-3,760
Change %
-0.34%
Price
$2.51
Shares after
1,086,787
Date
29 May 2025
Ownership
Direct
Footnotes
F1
NSPR transaction

Common Stock

Sale

Transaction value
$18,037
Shares
-7,186
Change %
-0.66%
Price
$2.51
Shares after
1,079,601
Date
30 May 2025
Ownership
Direct
Footnotes
F1
NSPR transaction

Common Stock

Sale

Transaction value
$4,676
Shares
-2,941
Change %
-0.27%
Price
$1.59
Shares after
1,076,660
Date
02 Feb 2026
Ownership
Direct
Footnotes
F1
NSPR transaction

Common Stock

Sale

Transaction value
$23,006
Shares
-22,778
Change %
-2.1%
Price
$1.01
Shares after
1,053,882
Date
19 May 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.

Footnote F2

The price reported is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $1.00 to $1.04. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .